go to The Japanese Society of Gastroenterological Surgery official site The Japanese Journal of Gastroenterological Surgery Online Journal
go to main navigation
go to Home
go to Current Issue
go to Past Issue
go to Article Search
Abstract go to Japanese page English
Vol.31 No.4 1998 April [Table of Contents] [Full text ( PDF 597KB)]
INVITED LECTURES

Effect of Anti-adhesion Therapy by a New Pseudo-peptide of Arg-Gly-Asp (RGD) on Tumor Metastasis

Yasuharu Ohnishi1)3), Hideki Fujii3), Jun Murata3), Takashi Sakamoto1), Kenji Tazawa2), Masao Fujimaki1), Ikuo Saiki3)

Second Department of Surgery1), Department of Clinical Nursing2), Faculty of Medicine, Department of Pathogenic Biochemistry3), Research Institute for Wakan-yaku, Toyama Medical and Pharmaceutical University

In order to augment the inhibitory effect on tumor invasion and metastasis, we synthesized a new pseudo-peptide of RGD sequence (FC-336) and examined its inhibitory effect on tumor metastasis in vivo and on the adhesion, migration and invasion of tumor cells in vitro. FC-336 significantly inhibited experimental lung metastasis produced by i.v. co-injection with B16-BL6 melanoma in a dose-dependent manner. The intraportal injection of FC-336 with colon 26-L5 cells, a highly liver-metastatic cell line of colon 26 carcinoma, resulted in marked suppression of metastatic colonies in the liver and reduction of the liver weight, whereas the co-injection of tumor cells with a high dose of RGDS led to slight inhibition of liver metastasis. Multiple i.v. injections of FC-336 after tumor inoculation or the co-injection of FC-336 with tumor cells caused significant inhibition of experimental liver metastasis. FC-336 significantly increased the survival rate for mice compared to untreated controls when co-injected intraportally with tumor cells or intravenously administered after tumor inoculation. Furthermore, FC-336 inhibited the invasion, migration and adhesion of tumor cells in vitro, but it was not more inhibitory than RGDS peptide. Zymographic analysis revealed that FC-336 inhibited the degradation of a gelatin substrate by matrix metalloproteinases (MMPs) produced by tumor cells, while RGDS peptide did not affect the enzymatic degradation. These results indicate that the pseudo-peptides of RGD sequence, possessing the inhibitory property of degradation by MMPs differently from the original RGD-containing peptides, may provide an advantageous and useful basis for preventing tumor metastasis.

Key words
pseudo-peptide, metastasis, matrix metalloproteinase (MMP)

Jpn J Gastroenterol Surg 31: 1004-1009, 1998

Reprint requests
Ikuo Saiki Department of Pathogenic Biochemistry, Research Institute for Wakan-Yaku, Toyama Medical and Pharmaceutical University 2630 Sugitani, Toyama, 930-0152 JAPAN

Accepted
December 3, 1997

go to download site To read the PDF file you will need Abobe Reader installed on your computer.
return to the head of this page
back to main navigation
Copyright © The Japanese Society of Gastroenterological Surgery